Cancerwise Podcast
what-is-personalized-ovarian-cancer-treatment [https://support.doctorpodcasting.com/media/k2/items/cache/593d5b47d8c14a8efb8befd4a35de5d9_S.jpg]https://support.doctorpodcasting.com/media/k2/items/cache/593d5b47d8c14a8efb8befd4a35de5d9_Generic.jpg Many ovarian cancer patients treated with chemotherapy or surgery still have a small number of cancer cells left in the body, called minimal residual disease (MRD). Amir Jazaeri, M.D., and Roni Nitecki Wilke, M.D., discuss how a minimally invasive procedure called a second-look laparoscopy can help detect MRD, and how clinical trials and immunotherapy could play a role in personalized ovarian cancer treatments.
41 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Cancerwise Podcast!